Proprietary Blend of Five Live Probiotic Strains Shown to Help Reduce Severity and Frequency of Common, Occasional GI Symptoms*
Now Rolling out to Major U.S. Retailers
LAVAL, QC, April 8, 2021 /PRNewswire/ --Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health“) today announced the U.S. launch of its novel daily over-the-counter probiotic supplement, ENVIVE. ENVIVE is shown to help reduce the severity and frequency of five occasional gastrointestinal (GI) symptoms - diarrhea, constipation, gas, bloating and discomfort - and help strengthen and protect the digestive system by strengthening the gut barrier. ENVIVE is proven to help relieve these occasional GI symptoms in as little as two weeks.*
“The launch of ENVIVE is another key example of Bausch Health's continued focus on bringing new products to market that help fulfill patients' needs,“ said Joseph C. Papa, chairman and CEO, Bausch Health. “Research indicates that approximately 61% of Americans have experienced one or more GI symptoms in the past week.1Leveraging our scientific knowledge and legacy of innovation in GI research, we specifically developed and clinically tested ENVIVE to offer consumers a new preservative-free, multi-strain probiotic designed to help relieve five occasional GI symptoms.“
In a healthy gut, probiotics or live organisms, help maintain a healthy balance of “good“ and “bad“ bacteria. Stress and poor diet, among other causes, can disrupt this balance, which can negatively affect overall digestive health. Probiotic supplements contain “good“ bacteria that, when consumed, can help restore the balance and may help protect the GI tract from harmful microorganisms that can negatively affect digestion and gut function. In a four-week study, participants taking ENVIVE experienced a reduction in the severity and frequency of five occasional GI symptoms at both weeks two and four, and 85% reported improved overall GI well-being. ENVIVE was also shown to help strengthen the gut barrier.